Sanderling Venture Partners VI Co Investment Fund LP's Net Worth
$3.05 Million
Who is Sanderling Venture Partners VI Co Investment Fund LP?
Sanderling Venture Partners VI Co Investment Fund LP has an estimated net worth of $3.05 Million. This is based on reported shares across multiple companies, which include CHIMERIX INC, Pacira Pharmaceuticals, Inc., ENDOCYTE INC, CARDIONET INC, CalciMedica, Inc., and FAVRILLE INC.
SEC CIK
Sanderling Venture Partners VI Co Investment Fund LP's CIK is 0001306695
Past Insider Trading and Trends
2014 was Sanderling Venture Partners VI Co Investment Fund LP's most active year for disposing of shares, totalling 2 transactions. Sanderling Venture Partners VI Co Investment Fund LP's most active month to dispose stocks was the month of August. In 2014 Sanderling Venture Partners VI Co Investment Fund LP cashed out on 100,000 shares for a total of $2,453,659.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Pacira Pharmaceuticals, Inc. (PCRX) Snapshot price: $13.89
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -2.86% | -295.48K |
$17.11 | -$9,721,916.67 | 10.05M |
Mar 7 - Mar 11
| |||
Form 4
| -21.31% | -424.87K |
$28.49 | -$7,052,064.97 | 1.57M |
Scheduled
|
Mar 15 - Mar 19
| ||
Form 4
| -58.75% | -800.00K |
—
|
—
| 561.76K |
Mar 15
| |||
Form 4
| -2.86% | -295.48K |
$17.11 | -$9,721,916.67 | 10.05M |
Mar 7 - Mar 11
| |||
Form 4
| -40.41% | -598.60K |
$18.93 | -$9,465,000.00 | 882.56K |
Dec 6 - Jan 24
| |||
Form 4
|
∞
| 221.48K |
$7.00 | $1,550,346.00 | 221.48K |
Feb 8
| |||
Form 4
|
∞
| 2.51M |
$7.00 | $324,653.00 | 2.51M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.8503
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.54% | -100.00K |
$24.54 | -$2,453,659.54 | 697.35K |
Sep 5 - Sep 8
| |||
Form 4
| -2.40% | -102.18K |
—
|
—
| 4.15M |
Nov 13
| |||
Form 4/A
| +22.87% | 792.04K |
—
|
—
| 4.26M |
Apr 16
| |||
Form 4
| +119.53% | 4.01M |
—
|
—
| 7.36M |
Apr 16 - Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOCYTE INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +36.99% | 395.6K |
$3.18 | $1,258,008.00 | 1.47M |
Dec 20 - Dec 21
| |||
Form 4
| +99.94% | 435.6K |
$3.18 | $1,385,208.00 | 871.46K |
Dec 20 - Dec 21
| |||
Form 4/A
| +657.49% | 1.29M |
—
|
—
| 1.48M |
Feb 9
| |||
Form 4
| +1,109.76% | 2.17M |
—
|
—
| 2.36M |
Feb 9
| |||
Form 4
|
∞
| 785.42K |
$6.00 | $4,712,502.00 | 785.42K |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CARDIONET INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.26% | -610.44K |
$26.50 | -$16,176,766.00 | 944.37K |
Aug 6
| |||
Form 4
|
∞
| 357.46K |
—
|
—
| 357.46K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CalciMedica, Inc. (CALC) Snapshot price: $5.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.71% | 87.74K |
$3.75 | $329,040.00 | 836.78K |
Nov 1
| |||
Form 4
| +41.84% | 679.38K |
$3.70 | $2,515,079.56 | 2.3M |
Jan 23
| |||
Form 4
|
∞
| 1.64M |
—
|
—
| 1.64M |
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||